Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind active-controlled study of a quadrivalent split inactivated influenza vaccine in people aged 3 years and older
CTR20243708Phase 3Active
- Sponsor
- Jiangsu Walvax Biotechnology
- Start
- Oct 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza vaccine in influenza, sponsored by Jiangsu Walvax Biotechnology. Started Oct 2024; status: active.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20243708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243708.